Skip to main content
Premium Trial:

Request an Annual Quote

Blue Cross and Blue Shield of Illinois to Cover CombiMatrix's Services

NEW YORK (GenomeWeb) – CombiMatrix announced today that it has entered into a contract with Blue Cross and Blue Shield of Illinois, the largest health plan in the state. Under the deal, BCBSIL members will have access to CombiMatrix's menu of CombiSNP microarray-based diagnostic testing services for developmental disorders and oncology.

CombiMatrix CEO Mark McDonough in a statement called the BCBSIL deal a "significant benefit to us as we continue to invest in this territory." He noted that Irvine, Calif.-based CombiMatrix recently expanded its sales and marketing presence in the Midwest and has seen increased sales activity as a result.

CombiMatrix has announced agreements with a number of organizations to expand access to its services this year. In July, Atlanta-based preferred provider organization network Stratose said it would cover CombiMatrix's suite of tests. In March, CombiMatrix partnered with American Pathology Partners to offer its microarray-based miscarriage testing service. And in January, it contracted with Galaxy Health Network to provide coverage of its tests for Galaxy's 3.5 million covered lives.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.